Presymptom Health

Presymptom Health is a pioneering medtech company that creates diagnostic tests to detect illnesses earlier to help save lives.

Established to exploit a ground-breaking innovation to detect infection and sepsis in patients up to three days before symptoms appear, Presymptom has recently secured nearly £2M of seed funding and support to enable it to conduct its multisite NHS PRECISION clinical trial, which began enrolling in May 2021. The company is developing a clinical diagnostic portfolio that will ultimately include tests for use at both point-of-care and within central laboratory settings.

Find out more

 

JANUARY 10 2023: PRESYMPTOM HEALTH WELCOMES NADIA WHITTLEY AS A NON-EXECUTIVE DIRECTOR

Nadia is an accomplished senior executive in the Life Sciences sector with experience across several therapeutic and diagnostic areas spanning EMEA, Asia Pacific and North America.

Read More

 

DECEMBER 6 2022: PRESYMPTOM MEDIA COVERAGE

Iain Miller recently spoke to UK Innovation & Science Seed Fund for their CEO Spotlight.

Read More

Investors

Presymptom Health is open to investment discussions to join us on our journey to create a truly revolutionary test for sepsis.

Find out more

Technology

Presymptom Health has a development plan to extend its clinical diagnostic test portfolio to include tests for both point of care and within central laboratories.

Find out more

View our latest news and articles

Latest News